Walleye Trading’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.1M | Buy |
21,638
+18,981
| +714% | +$3.57M | ﹤0.01% | 1422 |
|
|
2026
Q1 | $524K | Sell |
2,657
-26,102
| -91% | -$5.03M | ﹤0.01% | 2565 |
|
|
2025
Q4 | $5.29M | Sell |
28,759
-33,441
| -54% | -$5.87M | 0.01% | 1260 |
|
|
2025
Q3 | $9.54M | Buy |
62,200
+22,021
| +55% | +$3.33M | 0.01% | 922 |
|
|
2025
Q2 | $5.62M | Buy |
40,179
+7,050
| +21% | +$988K | 0.01% | 1147 |
|
|
2025
Q1 | $4.87M | Buy |
33,129
+30,607
| +1,214% | +$4.43M | 0.01% | 1114 |
|
|
2024
Q4 | $330K | Buy |
+2,522
| New | +$353K | ﹤0.01% | 2917 |
|
|
2024
Q2 | – | Sell |
-23,559
| Closed | -$3.55M | – | 4277 |
|
|
2024
Q1 | $3.19M | Buy |
+23,559
| New | +$3.12M | 0.01% | 1428 |
|
|
2023
Q4 | – | Sell |
-59,564
| Closed | -$7.74M | – | 5059 |
|
|
2023
Q3 | $8.07M | Buy |
+59,564
| New | +$8.14M | 0.02% | 790 |
|
|
2019
Q2 | – | Sell |
-30,941
| Closed | -$2.43M | – | 4022 |
|
|
2019
Q1 | $2.5M | Buy |
30,941
+277
| +0.9% | +$21.8K | 0.02% | 905 |
|
|
2018
Q4 | $2.33M | Buy |
+30,664
| New | +$2.39M | 0.02% | 955 |
|
|
2017
Q4 | – | Sell |
-6,612
| Closed | -$446K | – | 4333 |
|
|
2017
Q3 | $448 | Sell |
6,612
-178,268
| -96% | -$11.3M | ﹤0.01% | 2577 |
|
|
2017
Q2 | $12.6K | Buy |
184,880
+109,193
| +144% | +$7.13M | 0.08% | 220 |
|
|
2017
Q1 | $4.71K | Buy |
75,687
+54,178
| +252% | +$3.15M | 0.03% | 537 |
|
|
2016
Q4 | $1.18M | Sell |
21,509
-4,912
| -19% | -$279K | 0.01% | 1395 |
|
|
2016
Q3 | $1.74M | Buy |
+26,421
| New | +$1.73M | 0.01% | 1075 |
|
|
2016
Q2 | – | Sell |
-7,008
| Closed | -$407K | – | 5303 |
|
|
2016
Q1 | $395K | Sell |
7,008
-2,987
| -30% | -$179K | ﹤0.01% | 2168 |
|
|
2015
Q4 | $679K | Buy |
+9,995
| New | +$655K | 0.01% | 1590 |
|
|
2015
Q3 | – | Sell |
-37,729
| Closed | -$2.48M | – | 4949 |
|
|
2015
Q2 | $2.4M | Buy |
+37,729
| New | +$2.58M | 0.02% | 604 |
|
|
2015
Q1 | – | Sell |
-23,441
| Closed | -$1.63M | – | 4037 |
|
|
2014
Q4 | $1.65M | Sell |
23,441
-2,082
| -8% | -$149K | 0.01% | 769 |
|
|
2014
Q3 | $1.82M | Sell |
25,523
-30,356
| -54% | -$2.22M | 0.02% | 501 |
|
|
2014
Q2 | $4.15K | Buy |
55,879
+12,647
| +29% | +$914K | 0.06% | 174 |
|
|
2014
Q1 | $2.81K | Buy |
+43,232
| New | +$2.79M | 0.04% | 310 |
|
|
2013
Q3 | – | Sell |
-83,802
| Closed | -$3.96M | – | 2916 |
|
|
2013
Q2 | $3.96M | Buy |
+83,802
| New | +$4.27M | 0.04% | 356 |
|
Other funds holding AZN
EPGL
RG
SAM
CDDEC
MGP
Walleye Trading's AZN Position: Q2 2026 in Review
Walleye Trading increased its AstraZeneca (AZN) stake by 714% in Q2 2026, buying an estimated $3.57M and bringing the position to 21,638 shares worth $4.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1422.
Walleye Trading first reported a position in AZN in Q2 2013 and has held it in 24 quarters since. The position peaked at $9.54M in Q3 2025. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- Walleye Trading held 21,638 shares of AstraZeneca worth $4.1M as of Q2 2026.
- Walleye Trading bought 18,981 AstraZeneca shares in Q2 2026, an estimated $3.57M.
- AstraZeneca made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #1422 holding.
- Walleye Trading first reported a position in AstraZeneca in Q2 2013 and has held it in 24 quarters since.
- Walleye Trading's AstraZeneca position peaked at $9.54M in Q3 2025.
- 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.